ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Computational pathology applied to clinical colorectal cancer cohorts identifies immune and endothelial cell spatial patterns predictive of outcome

Trahearn, Nicholas; Sakr, Chirine; Banerjee, Abhirup; Lee, Seung Hyun; Baker, Ann-Marie; Kocher, Hemant M.; Angerilli, Valentina; Morano, Federica; Bergamo, Francesca; Maddalena, Giulia; Intini, Rossana; Cremolini, Chiara; Caravagna, Giulio; Graham, Trevor; Pietrantonio, Filippo; Lonardi, Sara*; Fassan, Matteo*; Sottoriva, Andrea*
Journal of Pathology2025-2DOI: 10.1002/path.6378
3阅读
引用收藏
分享

摘要

Colorectal cancer (CRC) is a histologically heterogeneous disease with variable clinical outcome. The role the tumour microenvironment (TME) plays in determining tumour progression is complex and not fully understood. To improve our understanding, it is critical that the TME is studied systematically within clinically annotated patient cohorts with long-term follow-up. Here we studied the TME in three clinical cohorts of metastatic CRC with diverse molecular subtype and treatment history. The MISSONI cohort included cases with microsatellite instability that received immunotherapy (n = 59, 24 months median follow-up). The BRAF cohort included BRAF V600E mutant microsatellite stable (MSS) cancers (n = 141, 24 months median follow-up). The VALENTINO cohort included RAS/RAF WT MSS cases who received chemotherapy and anti-EGFR therapy (n = 175, 32 months median follow-up). Using a Deep learning cell classifier, trained upon >38,000 pathologist annotations, to detect eight cell types within H&E-stained sections of CRC, we quantified the spatial tissue organisation and colocalisation of cell types across these cohorts. We found that the ratio of infiltrating endothelial cells to cancer cells, a possible marker of vascular invasion, was an independent predictor of progression-free survival (PFS) in the BRAF+MISSONI cohort (p = 0.033, HR = 1.44, CI = 1.029-2.01). In the VALENTINO cohort, this pattern was also an independent PFS predictor in TP53 mutant patients (p = 0.009, HR = 0.59, CI = 0.40-0.88). Tumour-infiltrating lymphocytes were an independent predictor of PFS in BRAF+MISSONI (p = 0.016, HR = 0.36, CI = 0.153-0.83). Elevated tumour-infiltrating macrophages were predictive of improved PFS in the MISSONI cohort (p = 0.031). We validated our cell classification using highly multiplexed immunofluorescence for 17 markers applied to the same sections that were analysed by the classifier (n = 26 cases). These findings uncovered important microenvironmental factors that underpin treatment response across and within CRC molecular subtypes, while providing an atlas of the distribution of 180 million cells in 375 clinically annotated CRC patients.

学科与关键词

关键词
computational pathologyartificial intelligencecolorectal cancerendotheliallymphocytemacrophage
相关
加载中…
  • Deep immunophenotyping reveals clinically distinct cellular states and ecosystems in large-scale colorectal cancer
    Li, Si; Pan, Tao; Xu, Gang; Gao, Yueying; Zhang, Ya; Xu, Qi; Pan, Jiwei; Zhou, Weiwei; Xu, Juan*; Li, Qifu*; Li, Yongsheng*Communications Biology, 2023, 6(1): 785.
  • Deep Learning Analysis of the Adipose Tissue and the Prediction of Prognosis in Colorectal Cancer
    Lin, Anqi; Qi, Chang; Li, Mujiao; Guan, Rui; Imyanitov, Evgeny N.; Mitiushkina, Natalia V.; Cheng, Quan; Liu, Zaoqu; Wang, Xiaojun; Lyu, Qingwen*; Zhang, Jian*; Luo, Peng*Frontiers in Nutrition, 2022, 9: 869263.被引 2
  • A deep learning quantified stroma-immune score to predict survival of patients with stage II-III colorectal cancer
    Xu, Zeyan; Li, Yong; Wang, Yingyi; Zhang, Shenyan; Huang, Yanqi; Yao, Su; Han, Chu; Pan, Xipeng; Shi, Zhenwei; Mao, Yun; Xu, Yao; Huang, Xiaomei; Lin, Huan; Chen, Xin; Liang, Changhong; Li, Zhenhui*; Zhao, Ke*; Zhang, Qingling*; Liu, Zaiyi*Cancer Cell International, 2021, 21(1): 585.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Pathology
发表日期
2025-02
卷期
第 265 卷, 第 2 期
页码
198-210
DOI
10.1002/path.6378
语言
ENGLISH
成果收录
SCIE
资助标注
Medical Research Council; Wellcome Trust; Cancer Research UK [A19771, DRCNPG-May21_100001]; CRUK Accelerator Award [A26815]; National Institutes of Health (NIH) [U54 CA217376]; Italian Ministry of Health/Veneto region [NET-2016-02363853]; AIRC 5 per mille [2019 (ID 22759)]; Italian Ministry of Health [GR-2019-12371132, C19941/A27859]; Canary Center at Stanford University; Oregon Health & Science University Knight Cancer Institute, University College London; University of Manchester; NIH [NCI U54 CA217376]; Centre for Evolution and Cancer [105104/Z/14/Z, IOV-IRCCS 5 x 1000, BIGID219ZAGO]; [MR/P000789/1]

作者

  • T

    Trahearn, Nicholas (第一作者)

  • S

    Sakr, Chirine

查看全部 18 位作者收起作者
  • B

    Banerjee, Abhirup

  • L

    Lee, Seung Hyun

  • B

    Baker, Ann-Marie

  • K

    Kocher, Hemant M.

  • A

    Angerilli, Valentina

  • M

    Morano, Federica

  • B

    Bergamo, Francesca

  • M

    Maddalena, Giulia

  • I

    Intini, Rossana

  • C

    Cremolini, Chiara

  • C

    Caravagna, Giulio

  • G

    Graham, Trevor

  • P

    Pietrantonio, Filippo

  • L

    Lonardi, Sara (通讯)

  • F

    Fassan, Matteo (通讯)

  • S

    Sottoriva, Andrea (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417